Response to: 'Correspondence on 'Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'' by Yang et al

Ann Rheum Dis. 2023 Apr;82(4):e80. doi: 10.1136/annrheumdis-2021-219855. Epub 2021 Jan 15.

Authors

Shintaro Akiyama¹, Shadi Hamdeh², Dejan Micic¹, Atsushi Sakuraba³

Affiliations

¹ Inflammatory Bowel Disease Center, The University of Chicago Medicine, Chicago, Illinois, USA.
² Department of Internal Medicine, Division of Gastroenterology, Hepatology and Motility, University of Kansas, Kansas City, Kansas, USA.
³ Inflammatory Bowel Disease Center, The University of Chicago Medicine, Chicago, Illinois, USA asakurab@medicine.bsd.uchicago.edu.

PMID: 33452000
DOI: 10.1136/annrheumdis-2021-219855

No abstract available

Keywords: COVID-19; autoimmune diseases; epidemiology.

Publication types

Letter
Comment

MeSH terms

Autoimmune Diseases* / complications
Autoimmune Diseases* / epidemiology
COVID-19*
Humans
Prevalence